420 With CNW - Israeli Researcher Behind THC's Discovery Dies At Age 92
(MENAFN- Investor Brand Network) Raphael Mechoulam, an Israeli scientist whose work advanced knowledge of marijuana and the chemical elements responsible for the drug's distinct high, has passed away. The 92-year-old Mechoulam passed away in Jerusalem last month. One of Mechoulam's major contributions to cannabis studies was the discovery of the psychoactive component of the marijuana plant: THC. He was given the moniker“Father of Marijuana Research” for his contributions.
Asher Cohen, president of the Hebrew University of Jerusalem, described Mechoulam as a charismatic and brilliant pioneer. Mechoulam was a...
read more>>
NOTE TO INVESTORS:
The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company's newsroom at
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published:
Do you have questions or are you interested in working with CNW420? ask our editor
CannabisNewsWire420
Denver, Colorado
303.498.7722 Office
CNW420 is part of the investorbrandnetwork .
MENAFN05042023000224011066ID1105951032
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.